Lv55
1150 积分 2024-04-02 加入
Abstract 2490: Quantification of tumor fraction and outcomes association in a real-world non-small cell lung cancer (NSCLC) cohort using a tissue agnostic epigenomic circulating tumor DNA (ctDNA) assay
24天前
已关闭
Clinical Utility of Tumor-Naïve Pre-surgical ctDNA Detection in Early-stage NSCLC
4个月前
已完结
Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers
4个月前
已完结
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer
6个月前
已完结
Abstract 3362: Evaluation of circulating tumor DNA kinetics as a prognostic biomarker for overall survival in metastatic castrate resistant prostate cancer using a novel methylation sequencing research assay
7个月前
已关闭
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients
7个月前
已完结
Two cases of non-small cell lung cancer patients with somatic or germline EGFR R776H mutation
7个月前
已完结
A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy
7个月前
已完结
皖公网安备34019202002308
